Laura Cohen is the Vice President for Environment Shaping in Eli Lilly and Company’s Neuroscience Corporate Affairs group where she focuses on policy, access, and reimbursement issues for Alzheimer’s disease therapeutics, diagnostics, and screening. Previously, Laura was the head of environment shaping and health policy for Lilly’s Immunology business unit where she worked across dermatology, rheumatology, and gastroenterology. Before joining Lilly, Laura practiced law at several large law firms, including Sidley Austin, LLP, and was an in-house counsel for a Massachusetts health insurance company where she focused on regulatory and government affairs issues. Laura began her career in health policy at Brigham and Women’s Hospital in Boston, MA at the Mary Horrigan Connors Center for Women's Health and Gender Biology. Laura holds a BA with honors from Brandeis University in History and Health Policy and a JD with honors from Suffolk University Law School’s evening program.